Cargando…

Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series

OBJECTIVE: The serrated pathway is a distinct genetic/epigenetic mechanism of the adenoma-carcinoma sequence in colorectal carcinogenesis. Although many groups have reported the genetic-phenotypic correlation of serrated lesions (SLs), previous studies regarding the serrated pathway were conducted o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidaka, Misaki, Iwaizumi, Moriya, Taniguchi, Terumi, Baba, Satoshi, Osawa, Satoshi, Sugimoto, Ken, Maekawa, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682711/
https://www.ncbi.nlm.nih.gov/pubmed/36419139
http://dx.doi.org/10.1186/s13104-022-06245-3
_version_ 1784834911814811648
author Hidaka, Misaki
Iwaizumi, Moriya
Taniguchi, Terumi
Baba, Satoshi
Osawa, Satoshi
Sugimoto, Ken
Maekawa, Masato
author_facet Hidaka, Misaki
Iwaizumi, Moriya
Taniguchi, Terumi
Baba, Satoshi
Osawa, Satoshi
Sugimoto, Ken
Maekawa, Masato
author_sort Hidaka, Misaki
collection PubMed
description OBJECTIVE: The serrated pathway is a distinct genetic/epigenetic mechanism of the adenoma-carcinoma sequence in colorectal carcinogenesis. Although many groups have reported the genetic-phenotypic correlation of serrated lesions (SLs), previous studies regarding the serrated pathway were conducted on patients with SLs that have different germline and environmental genetic backgrounds. We aimed to compare pure somatic genetic profiles among SLs within identical patient with SPS. RESULTS: We analyzed SLs from one patient with SPS (Case #1) and compared DNA variant profiles using targeted DNA multigene panels via NGS among the patient’s hyperplastic polyp (HP), three sessile serrated lesions (SSLs), and one traditional serrated adenoma (TSA), and separately analyzed three SSLs and one tubular adenoma (TA) within another patient with SPS (Case #2). In two patients, known pathogenic variant of BRAF (c.1799 T > A, p.Val600Glu) was observed in one TSA and one SSL in Case #1, and in three SSLs within Case #2. The pure somatic pathogenic variant BRAF (c.1799 T > A, p.Val600Glu) among SLs with identical germline genetic background supports its importance as a strong contributor for SLs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-022-06245-3.
format Online
Article
Text
id pubmed-9682711
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96827112022-11-24 Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series Hidaka, Misaki Iwaizumi, Moriya Taniguchi, Terumi Baba, Satoshi Osawa, Satoshi Sugimoto, Ken Maekawa, Masato BMC Res Notes Research Note OBJECTIVE: The serrated pathway is a distinct genetic/epigenetic mechanism of the adenoma-carcinoma sequence in colorectal carcinogenesis. Although many groups have reported the genetic-phenotypic correlation of serrated lesions (SLs), previous studies regarding the serrated pathway were conducted on patients with SLs that have different germline and environmental genetic backgrounds. We aimed to compare pure somatic genetic profiles among SLs within identical patient with SPS. RESULTS: We analyzed SLs from one patient with SPS (Case #1) and compared DNA variant profiles using targeted DNA multigene panels via NGS among the patient’s hyperplastic polyp (HP), three sessile serrated lesions (SSLs), and one traditional serrated adenoma (TSA), and separately analyzed three SSLs and one tubular adenoma (TA) within another patient with SPS (Case #2). In two patients, known pathogenic variant of BRAF (c.1799 T > A, p.Val600Glu) was observed in one TSA and one SSL in Case #1, and in three SSLs within Case #2. The pure somatic pathogenic variant BRAF (c.1799 T > A, p.Val600Glu) among SLs with identical germline genetic background supports its importance as a strong contributor for SLs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-022-06245-3. BioMed Central 2022-11-22 /pmc/articles/PMC9682711/ /pubmed/36419139 http://dx.doi.org/10.1186/s13104-022-06245-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Note
Hidaka, Misaki
Iwaizumi, Moriya
Taniguchi, Terumi
Baba, Satoshi
Osawa, Satoshi
Sugimoto, Ken
Maekawa, Masato
Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series
title Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series
title_full Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series
title_fullStr Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series
title_full_unstemmed Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series
title_short Pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series
title_sort pure somatic pathogenic variation profiles for patients with serrated polyposis syndrome: a case series
topic Research Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682711/
https://www.ncbi.nlm.nih.gov/pubmed/36419139
http://dx.doi.org/10.1186/s13104-022-06245-3
work_keys_str_mv AT hidakamisaki puresomaticpathogenicvariationprofilesforpatientswithserratedpolyposissyndromeacaseseries
AT iwaizumimoriya puresomaticpathogenicvariationprofilesforpatientswithserratedpolyposissyndromeacaseseries
AT taniguchiterumi puresomaticpathogenicvariationprofilesforpatientswithserratedpolyposissyndromeacaseseries
AT babasatoshi puresomaticpathogenicvariationprofilesforpatientswithserratedpolyposissyndromeacaseseries
AT osawasatoshi puresomaticpathogenicvariationprofilesforpatientswithserratedpolyposissyndromeacaseseries
AT sugimotoken puresomaticpathogenicvariationprofilesforpatientswithserratedpolyposissyndromeacaseseries
AT maekawamasato puresomaticpathogenicvariationprofilesforpatientswithserratedpolyposissyndromeacaseseries